drugset / Trial / NCT00489918
Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Multi-center study to determine effects of various doses of Macroflux Parathryroid Hormone (PTH) in women with osteoporosis
Timeline
- Start
- 2007-06
- Primary completion
- 2008-04
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Teriparatide | Protein / enzyme biologic | 20 ug | Other |
| Comparator | Teriparatide | Protein / enzyme biologic | 20 ug | Subcutaneous |
| Comparator | Teriparatide | Protein / enzyme biologic | 30 ug | Other |
| Comparator | Teriparatide | Protein / enzyme biologic | 40 ug | Other |